Oncolytic viruses: focusing on the tumor microenvironment

被引：20

作者：

de Vries, C. R.

Kaufman, H. L.

Lattime, E. C. ^{[1
]}

机构：

[1] Rutgers State Univ, Rutgers Robert Wood Johnson Med Sch, Rutgers Canc Inst New Jersey, New Brunswick, NJ 08903 USA

来源：

CANCER GENE THERAPY | 2015年 / 22卷 / 04期

关键词：

PHASE-I; INTRATUMORAL VACCINATION; IMMUNE ESCAPE; CELLS; CANCER; INTERLEUKIN-10; ANTIGEN; POXVIRUS; JX-594;

D O I：

10.1038/cgt.2015.11

中图分类号：

Q81 [生物工程学（生物技术）]; Q93 [微生物学];

学科分类号：

071005 [微生物学]; 090105 [作物生产系统与生态工程];

摘要：

引用

收藏

页码：169 / 171

页数：3

相关论文

共 25 条

[1]

Intravenous delivery of a multi-mechanistic cancer-targeted oncolytic poxvirus in humans [J].

Breitbach, Caroline J. ;

Burke, James ;

Jonker, Derek ;

Stephenson, Joe ;

Haas, Andrew R. ;

Chow, Laura Q. M. ;

Nieva, Jorge ;

Hwang, Tae-Ho ;

Moon, Anne ;

Patt, Richard ;

Pelusio, Adina ;

Le Boeuf, Fabrice ;

Burns, Joe ;

Evgin, Laura ;

De Silva, Naomi ;

Cvancic, Sara ;

Robertson, Terri ;

Je, Ji-Eun ;

Lee, Yeon-Sook ;

Parato, Kelley ;

Diallo, Jean-Simon ;

Fenster, Aaron ;

Daneshmand, Manijeh ;

Bell, John C. ;

Kirn, David H. .

NATURE, 2011, 477 (7362) :99-U102

[2]

The addition of recombinant vaccinia HER2/neu to oncolytic vaccinia-GMCSF given into the tumor microenvironment overcomes MDSC-mediated immune escape and systemic anergy [J].

de Vries, C. R. ;

Monken, C. E. ;

Lattime, E. C. .

CANCER GENE THERAPY, 2015, 22 (03) :154-162

[3]

Measles virus causes immunogenic cell death in human melanoma [J].

Donnelly, O. G. ;

Errington-Mais, F. ;

Steele, L. ;

Hadac, E. ;

Jennings, V. ;

Scott, K. ;

Peach, H. ;

Phillips, R. M. ;

Bond, J. ;

Pandha, H. ;

Harrington, K. ;

Vile, R. ;

Russell, S. ;

Selby, P. ;

Melcher, A. A. .

GENE THERAPY, 2013, 20 (01) :7-15

[4]

Phase I study of intraprostatic vaccine administration in men with locally recurrent or progressive prostate cancer [J].

Gulley, James L. ;

Heery, Christopher R. ;

Madan, Ravi A. ;

Walter, Beatriz A. ;

Merino, Maria J. ;

Dahut, William L. ;

Tsang, Kwong-Yok ;

Schlom, Jeffrey ;

Pinto, Peter A. .

CANCER IMMUNOLOGY IMMUNOTHERAPY, 2013, 62 (09) :1521-1531

[5]

Oncolytic viruses as platform for multimodal cancer therapeutics: a promising land [J].

Guo, Z. S. ;

Bartlett, D. L. .

CANCER GENE THERAPY, 2014, 21 (07) :261-263

[6]

Halak BK, 1999, CANCER RES, V59, P911

[7]

Kaufman HL, 2001, HUM GENE THER, V12, P1459

[8]

Local and Distant Immunity Induced by Intralesional Vaccination with an Oncolytic Herpes Virus Encoding GM-CSF in Patients with Stage IIIc and IV Melanoma [J].

Kaufman, Howard L. ;

Kim, Dae Won ;

DeRaffele, Gail ;

Mitcham, Josephine ;

Coffin, Rob S. ;

Kim-Schulze, Seunghee .

ANNALS OF SURGICAL ONCOLOGY, 2010, 17 (03) :718-730

[9]

Intratumoral vaccination and diversified subcutaneous/intratumoral vaccination with recombinant poxviruses encoding a tumor antigen and multiple costimulatory molecules [J].

Kudo-Saito, C ;

Schlom, J ;

Hodge, JW .

CLINICAL CANCER RESEARCH, 2004, 10 (03) :1090-1099

[10]

Functional characterization of human Cd33+ And Cd11b+ myeloid-derived suppressor cell subsets induced from peripheral blood mononuclear cells co-cultured with a diverse set of human tumor cell lines [J].

Lechner, Melissa G. ;

Megiel, Carolina ;

Russell, Sarah M. ;

Bingham, Brigid ;

Arger, Nicholas ;

Woo, Tammy ;

Epstein, Alan L. .

JOURNAL OF TRANSLATIONAL MEDICINE, 2011, 9